KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $887.9 million.

  • Idexx Laboratories' Consolidated Net Income rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
  • Latest data reveals that Idexx Laboratories reported Consolidated Net Income of $887.9 million as of FY2024, which was up 5.07% from $845.0 million recorded in FY2023.
  • Idexx Laboratories' Consolidated Net Income's 5-year high stood at $887.9 million during FY2024, with a 5-year trough of $582.1 million in FY2020.
  • For the 3-year period, Idexx Laboratories' Consolidated Net Income averaged around $804.0 million, with its median value being $845.0 million (2023).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first skyrocketed by 36.08% in 2020, then fell by 8.83% in 2022.
  • Yearly analysis of 5 years shows Idexx Laboratories' Consolidated Net Income stood at $582.1 million in 2020, then rose by 27.95% to $744.8 million in 2021, then decreased by 8.83% to $679.1 million in 2022, then climbed by 24.44% to $845.0 million in 2023, then increased by 5.07% to $887.9 million in 2024.